Title 42 › CHAPTER 163 — RESEARCH AND DEVELOPMENT, COMPETITION, AND INNOVATION › SUBCHAPTER IV — BIOECONOMY RESEARCH AND DEVELOPMENT › § 19134
The agency co‑chair of the interagency committee must work with the White House Office of Science and Technology Policy to set up an advisory committee on engineering biology research and development. The committee must have at least 12 members from universities, research groups, industry, and nonprofits who can give expert advice on the Initiative. The committee must review U.S. competitiveness and investments in engineering biology, market barriers to bringing products to market, progress and possible changes to the Initiative, the balance of activities and funding, whether the plan keeps the U.S. a leader, and whether ethical, legal, environmental, safety, security, and other social issues are being handled. The first report is due no later than two years after August 9, 2022, and then at least once every five years. Reports go to the President and the relevant House and Senate committees, and must include findings and recommendations. Section 14 of the Federal Advisory Committee Act does not apply to this committee. The committee ends 10 years after August 9, 2022.
Full Legal Text
The Public Health and Welfare, Source: USLM XML via OLRC
Legislative History
Reference
Citation
42 U.S.C. § 19134
Title 42, The Public Health and Welfare
Last Updated
Sep 23, 2026
Release point: 119-110